Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, et al. Screening for colorectal Cancer: US preventive services task force recommendation statement. JAMA. 2021;325(19):1965–77.
Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145–64.
Zauber AG. The impact of screening on colorectal cancer mortality and incidence: has it really made a difference? Dig Dis Sci. 2015;60(3):681–91.
Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW Jr, García FAR, et al. Screening for colorectal Cancer: US preventive services task force recommendation statement. JAMA. 2016;315(23):2564–75.
Meester RG, Doubeni CA, Lansdorp-Vogelaar I, Goede SL, Levin TR, Quinn VP, et al. Colorectal cancer deaths attributable to nonuse of screening in the United States. Ann Epidemiol. 2015;25(3):208–13 e1.
D'Andrea E, Ahnen DJ, Sussman DA, Najafzadeh M. Quantifying the impact of adherence to screening strategies on colorectal cancer incidence and mortality. Cancer Med. 2020;9(2):824–36.
Nielson CM, Vollmer WM, Petrik AF, Keast EM, Green BB, Coronado GD. Factors affecting adherence in a pragmatic trial of annual fecal immunochemical testing for colorectal Cancer. J Gen Intern Med. 2019;34(6):978–85.
Subramanian S, Tangka FK, Hoover S, Beebe MC, DeGroff A, Royalty J, et al. Costs of planning and implementing the CDC's colorectal Cancer screening demonstration program. Cancer. 2013;119(Suppl 15):2855–62.
Walsh JM, Salazar R, Nguyen TT, Kaplan C, Nguyen LK, Hwang J, et al. Healthy colon, healthy life: a novel colorectal cancer screening intervention. Am J Prev Med. 2010;39(1):1–14.
Coronado GD, Golovaty I, Longton G, Levy L, Jimenez R. Effectiveness of a clinic-based colorectal cancer screening promotion program for underserved Hispanics. Cancer. 2011;117(8):1745–54.
Church TR, Yeazel MW, Jones RM, Kochevar LK, Watt GD, Mongin SJ, et al. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. J Natl Cancer Inst. 2004;96(10):770–80.
Myers RE, Sifri R, Hyslop T, Rosenthal M, Vernon SW, Cocroft J, et al. A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer. 2007;110(9):2083–91.
Nielson CM, Petrik AF, Jacob L, Vollmer WM, Keast EM, Schneider JL, et al. Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial. Cancer Med. 2018;7(9):4781–90.
Pham R, Cross S, Fernandez B, Corson K, Dillon K, Yackley C, et al. "finding the right FIT": rural patient preferences for fecal immunochemical test (FIT) characteristics. J Am Board Fam Med. 2017;30(5):632–44.
Bharti B, May FFP, Nodora J, Martínez ME, Moyano K, Davis SL, et al. Diagnostic colonoscopy completion after abnormal fecal immunochemical testing and quality of tests used at 8 federally qualified health centers in Southern California: opportunities for improving screening outcomes. Cancer. 2019;125(23):4203–9.
Davis MM, Freeman M, Shannon J, Coronado GD, Stange KC, Guise JM, et al. A systematic review of clinic and community intervention to increase fecal testing for colorectal cancer in rural and low-income populations in the United States - how, what and when? BMC Cancer. 2018;18(1):40.
Dougherty MK, Brenner AT, Crockett SD, Gupta S, Wheeler SB, Coker-Schwimmer M, et al. Evaluation of interventions intended to increase colorectal Cancer screening rates in the United States: a systematic review and Meta-analysis. JAMA Intern Med. 2018;178(12):1645–58.
Gupta S, Coronado GD, Argenbright K, Brenner AT, Castañeda SF, Dominitz JA, et al. Mailed fecal immunochemical test outreach for colorectal cancer screening: summary of a Centers for Disease Control and Prevention-sponsored summit. CA Cancer J Clin. 2020;70(4):283–98.
Jager M, Demb J, Asghar A, Selby K, Mello EM, Heskett KM, et al. Mailed outreach is superior to usual care alone for colorectal Cancer screening in the USA: a systematic review and Meta-analysis. Dig Dis Sci. 2019;64(9):2489–96.
Gupta S, Lieberman D. Screening and surveillance colonoscopy and COVID-19: avoiding more casualties. Gastroenterology. 2020;159(4):1205–8.
Issaka RB, Somsouk M. Colorectal Cancer screening and prevention in the COVID-19 era. JAMA Health Forum. 2020;1(5):e200588.
Corley DA, Sedki M, Ritzwoller DP, Greenlee RT, Neslund-Dudas C, Rendle KA, et al. Cancer screening during the coronavirus Disease-2019 pandemic: a perspective from the National Cancer Institute's PROSPR consortium. Gastroenterology. 2021;160(4):999–1002.
Mast CaMdR. Alejandro COVID-19 weekly volumes for preventive cancer screenings for breast, colon, and cervical cancer are 86-94% lower than 2017-2019 historical averages. Epic Health Resh Netw. 2020; Available from: https://ehrn.org/articles/delays-in-preventive-cancer-screenings-during-covid-19-pandemic/.
Ateev Mehrotra MC, David Linetsky, Hilary Hatch, and David Cutler. The Commonwealth Fund. 2020. Available from: https://www.commonwealthfund.org/publications/2020/apr/impact-covid-19-outpatient-visits. [cited 2021 2/9/2021]
Harvey G, Kitson A. PARIHS revisited: from heuristic to integrated framework for the successful implementation of knowledge into practice. Implement Sci. 2016;11:33.
Shea CM, Jacobs SR, Esserman DA, Bruce K, Weiner BJ. Organizational readiness for implementing change: a psychometric assessment of a new measure. Implement Sci. 2014;9:7.
Gill Harvey AK. Implementing Evidence-Based Practice in Healthcare. 1st ed: Routledge; 2015. p. 240.
Coronado GD, Green BB, West II, Schwartz MR, Coury JK, Vollmer WM, et al. Direct-to-member mailed colorectal cancer screening outreach for Medicaid and Medicare enrollees: implementation and effectiveness outcomes from the BeneFIT study. Cancer. 2020;126(3):540–8.
Coury JK, Schneider JL, Green BB, Baldwin LM, Petrik AF, Rivelli JS, et al. Two Medicaid health plans' models and motivations for improving colorectal cancer screening rates. Transl Behav Med. 2020;10(1):68–77.
Meenan RT, Coronado GD, Petrik A, Green BB. A cost-effectiveness analysis of a colorectal cancer screening program in safety net clinics. Prev Med. 2019;120:119–25.
Meenan RT, Baldwin LM, Coronado GD, Schwartz M, Coury J, Petrik AF, et al. Costs of two health insurance plan programs to mail fecal immunochemical tests to Medicare and Medicaid plan members. Popul Health Manag. 2020;24(2):255–65.
Davis MM, Renfro S, Pham R, Hassmiller Lich K, Shannon J, Coronado GD, et al. Geographic and population-level disparities in colorectal cancer testing: a multilevel analysis of Medicaid and commercial claims data. Prev Med. 2017;101:44–52.
Davis MM, Nambiar S, Mayorga ME, Sullivan E, Hicklin K, O'Leary MC, et al. Mailed FIT (fecal immunochemical test), navigation or patient reminders? Using microsimulation to inform selection of interventions to increase colorectal cancer screening in Medicaid enrollees. Prev Med. 2019;129s:105836.
Fagnan LJ, Morris C, Shipman SA, Holub J, King A, Angier H. Characterizing a practice-based research network: Oregon rural practice-based research Network (ORPRN) survey tools. J Am Board Fam Med. 2007;20(2):204–19.
Solberg LI, Asche SE, Margolis KL, Whitebird RR. Measuring an organization's ability to manage change: the change process capability questionnaire and its use for improving depression care. Am J Med Qual. 2008;23(3):193–200.
Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.
Adams SA, Rohweder CL, Leeman J, Friedman DB, Gizlice Z, Vanderpool RC, et al. Use of evidence-based interventions and implementation strategies to increase colorectal Cancer screening in federally qualified health centers. J Community Health. 2018;43(6):1044–52.
Coury J, Schneider JL, Rivelli JS, Petrik AF, Seibel E, D'Agostini B, et al. Applying the plan-do-study-act (PDSA) approach to a large pragmatic study involving safety net clinics. BMC Health Serv Res. 2017;17(1):411.
Mojica CM, Gunn R, Pham R, Miech EJ, Romer A, Renfro S, Clark KD, Davis MM. An observational study of workflows to support fecal testing for colorectal cancer screening in primary care practices serving Medicaid enrollees. BMC Cancer. 2022;22(1):106. https://doi.org/10.1186/s12885-021-09106-7.
Nagykaldi Z, Mold JW, Robinson A, Niebauer L, Ford A. Practice facilitators and practice-based research networks. J Am Board Fam Med. 2006;19(5):506–10.
Network ORP-bR. Oregon rural practice-based research Network: what we do. Portland, Oregon: Oregon Health & Science University; 2021. Available from: https://www.ohsu.edu/oregon-rural-practice-based-research-network. [cited 2021].
Health OOoR. Spreadsheet of Oregon Zip Codes, Towns, Cities and Service Areas and their ORH Urban/Rural/Frontier Designation. In: Designation.xls OZCTCaSAatOURF; 2019. Spreadsheet.
Cox NJ. TABCOUNT: Stata module to tabulate frequencies, with zeros explicit statistical software components S429501 Boston College Department of economics; 2002. Available from: https://ideas.repec.org/c/boc/bocode/s429501.html. [updated revised 24 Sep 2004]
Tangka FK, Subramanian S, Beebe MC, Hoover S, Royalty J, Seeff LC. Clinical costs of colorectal cancer screening in 5 federally funded demonstration programs. Cancer. 2013;119 Suppl 15(0 15):2863–9.
Chiang TH, Chuang SL, Chen SL, Chiu HM, Yen AM, Chiu SY, et al. Difference in performance of fecal immunochemical tests with the same hemoglobin cutoff concentration in a nationwide colorectal cancer screening program. Gastroenterology. 2014;147(6):1317–26.
Coronado GD, Schneider JL, Petrik A, Rivelli J, Taplin S, Green BB. Implementation successes and challenges in participating in a pragmatic study to improve colon cancer screening: perspectives of health center leaders. Transl Behav Med. 2017;7(3):557–66.
Foutz JAS, Garfield R. The role of Medicaid in rural America: Issue Brief The Henry J Kaiser Family Foundation; 2017.
Kurani SS, McCoy RG, Lampman MA, Doubeni CA, Finney Rutten LJ, Inselman JW, et al. Association of Neighborhood Measures of social determinants of health with breast, cervical, and colorectal Cancer screening rates in the US Midwest. JAMA Netw Open. 2020;3(3):e200618.
Subramanian S, Tangka FKL, Hoover S, Cole-Beebe M, Joseph D, DeGroff A. Comparison of program resources required for colonoscopy and fecal screening: findings from 5 years of the colorectal Cancer control program. Prev Chronic Dis. 2019;16:E50.
Liles EG, Schneider JL, Feldstein AC, Mosen DM, Perrin N, Rosales AG, et al. Implementation challenges and successes of a population-based colorectal cancer screening program: a qualitative study of stakeholder perspectives. Implement Sci. 2015;10:41.
Hudson SV, Ferrante JM, Ohman-Strickland P, Hahn KA, Shaw EK, Hemler J, et al. Physician recommendation and patient adherence for colorectal cancer screening. J Am Board Fam Med. 2012;25(6):782–91.
Gilbert A, Kanarek N. Colorectal cancer screening: physician recommendation is influential advice to Marylanders. Prev Med. 2005;41(2):367–79.
Coronado GD. Who is reached with clinic in-reach and outreach strategies to promote colorectal Cancer screening? Am J Public Health. 2020;110(4):437–9.
Castañeda SF, Bharti B, Espinoza-Giacinto RA, Sanchez V, O'Connell S, Muñoz F, et al. Evaluating two evidence-based intervention strategies to promote CRC screening among Latino adults in a primary care setting. J Racial Ethn Health Disparities. 2018;5(3):530–5.
Brtnikova M, Crane LA, Allison MA, Hurley LP, Beaty BL, Kempe A. A method for achieving high response rates in national surveys of U.S. primary care physicians. PLoS One. 2018;13(8):e0202755.
McLeod CC, Klabunde CN, Willis GB, Stark D. Health care provider surveys in the United States, 2000-2010: a review. Eval Health Prof. 2013;36(1):106–26.
Cull WL, O'Connor KG, Sharp S, Tang SF. Response rates and response bias for 50 surveys of pediatricians. Health Serv Res. 2005;40(1):213–26.
Roberts DL, Shanafelt TD, Dyrbye LN, West CP. A national comparison of burnout and work-life balance among internal medicine hospitalists and outpatient general internists. J Hosp Med. 2014;9(3):176–81.